Autologous Stem Cell Transplant (ASCT) is a myeloma treatment that has stood the test of time, because it is widely considered safe and effective for a wide range of myeloma patients. Many consider a transplant as their first myeloma therapy, and those who don’t will probably still want to have the option later to do one. This series, taught by world experts on ASCT for multiple myeloma patients was created to teach you the ins and outs of ASCT to help you make the best decision for your best outcomes.
Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. We invite you to watch these, and also visit HealthTree University and creating a HealthTree account. By creating a HealthTree account, in HealthTree University you can:
7.07 - What are the benefits and risks of inpatient vs outpatient transplant?
7.08 - What's involved in the stem cell collection process?
7.09 - When is the ideal time to collect stem cells? Should you treat to as deep of a response as possible prior to collecting stem cells?
7.10 - Do myeloma cells get included in the stem cell collection and infusion during ASCT?
We’d like to thank our faculty who donated their time in creating these videos, including:
We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
Other HealthTree University Classes:
about the author
Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.